Analyzing Stock On Your Own: Radiopharm Theranostics Ltd ADR (NASDAQ: RADX)

Radiopharm Theranostics Ltd ADR (NASDAQ:RADX) does about 73.56K shares in volume on a normal day but saw 7686377 shares change hands in the recent trading day. The company now has a market cap of 42.79M USD. Its current market price is $5.50, marking an increase of 10.00% compared to the previous close of $5.00. The 52 week high reached by this stock is $50.82 whilst the lowest price level in 52 weeks is $3.55.

Radiopharm Theranostics Ltd ADR (RADX) has a 20-day trading average at $4.77 and the current price is -89.18% off the 52-week high compared with 54.93% distance from its 52-week low. The 50-day simple moving average of the closing price is $4.77. If we look at the stock’s price movements over the week, volatility stands at 35.04%, which decreases to 15.00% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 52.78 to suggest the stock is neutral.

The current price level is 15.42%, 15.31%, and 2.00% away from its SMA20, SMA50, and SMA200 respectively, with the RADX price moving below the 50-day SMA on current market day. Radiopharm Theranostics Ltd ADR (RADX) stock is up 18.53% over the week and 15.79% over the past month. Its price is 22.49% year-to-date.

The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year.

Outstanding shares total 7.34M with insiders holding 0.00% of the shares and institutional holders owning 6.77% of the company’s common stock. The company has a return on investment of -83.91% and return on equity of -111.73%. Price to book ratio is 1.22 and price to sales ratio is 38.55.